BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 40 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $15,899,000 | -61.3% | 15,004,000 | -60.3% | 0.35% | -56.5% |
| Q4 2019 | $41,037,000 | +4.7% | 37,781,000 | -0.4% | 0.80% | +8.3% |
| Q3 2019 | $39,192,000 | +23.4% | 37,943,000 | +34.3% | 0.73% | +19.3% |
| Q2 2019 | $31,757,000 | +21.8% | 28,256,000 | +23.7% | 0.62% | +7.0% |
| Q1 2019 | $26,075,000 | +0.8% | 22,844,000 | -1.3% | 0.58% | -8.0% |
| Q4 2018 | $25,858,000 | -12.3% | 23,153,000 | -6.0% | 0.62% | +2.8% |
| Q3 2018 | $29,496,000 | -0.4% | 24,635,000 | -1.5% | 0.61% | -2.4% |
| Q2 2018 | $29,619,000 | +3.7% | 25,021,000 | -3.2% | 0.62% | +11.1% |
| Q1 2018 | $28,571,000 | +0.2% | 25,845,000 | +7.5% | 0.56% | +2.7% |
| Q4 2017 | $28,517,000 | -8.1% | 24,045,000 | -6.8% | 0.55% | -7.1% |
| Q3 2017 | $31,041,000 | -2.2% | 25,805,000 | -3.2% | 0.59% | -3.1% |
| Q2 2017 | $31,736,000 | -1.9% | 26,646,000 | -2.1% | 0.61% | +0.3% |
| Q1 2017 | $32,366,000 | +0.1% | 27,224,000 | -0.6% | 0.60% | +1.7% |
| Q4 2016 | $32,334,000 | -2.7% | 27,377,000 | +2.9% | 0.60% | +24.0% |
| Q3 2016 | $33,221,000 | +2.2% | 26,599,000 | -5.1% | 0.48% | -4.6% |
| Q2 2016 | $32,497,000 | +1.1% | 28,035,000 | +3.6% | 0.50% | +2.4% |
| Q1 2016 | $32,137,000 | -1.0% | 27,058,000 | +12.5% | 0.49% | -1.8% |
| Q4 2015 | $32,458,000 | +6.6% | 24,058,000 | +6.7% | 0.50% | +7.3% |
| Q3 2015 | $30,444,000 | -26.2% | 22,554,000 | -12.4% | 0.47% | -21.4% |
| Q2 2015 | $41,264,000 | -7.4% | 25,758,000 | -12.7% | 0.59% | -7.9% |
| Q1 2015 | $44,549,000 | +21.0% | 29,503,000 | -2.5% | 0.64% | +19.0% |
| Q4 2014 | $36,807,000 | -6.3% | 30,259,000 | -15.4% | 0.54% | -10.6% |
| Q3 2014 | $39,268,000 | +1.0% | 35,763,000 | 0.0% | 0.60% | +4.3% |
| Q2 2014 | $38,870,000 | -9.2% | 35,763,000 | -6.9% | 0.58% | -13.2% |
| Q1 2014 | $42,798,000 | -15.0% | 38,429,000 | -17.9% | 0.67% | +5.4% |
| Q4 2013 | $50,350,000 | – | 46,800,000 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | 12,400,000 | $1,340,750,000,000 | 1.66% |
| OAKTREE CAPITAL MANAGEMENT LP | 66,800,000 | $70,446,000 | 1.23% |
| Man Investments (CH) AG | 2,600,000 | $2,743,000 | 1.11% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $8,425,000 | 0.81% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 35,763,000 | $38,870,000 | 0.58% |
| Jabre Capital Partners S.A. | 5,900,000 | $6,240,000 | 0.44% |
| SSI INVESTMENT MANAGEMENT LLC | 3,039,000 | $3,198,000 | 0.31% |
| AVIVA PLC | 37,700,000 | $39,724,000 | 0.30% |
| BNP PARIBAS FINANCIAL MARKETS | 3,000,000 | $315,929,984,000 | 0.30% |
| Calamos Advisors LLC | 44,222,000 | $46,596,000 | 0.30% |